01455nam 2200349 n 450 991067437320332120230627104718.0(CKB)5400000000045123(NjHacI)995400000000045123(EXLCZ)99540000000004512320230627d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierMonoclonal Antibody-Directed Therapy /Veysel Kayser, Amita Datta-MannanBasel, Switzerland :MDPI - Multidisciplinary Digital Publishing Institute,2022.1 online resource (142 pages)3-0365-2873-3 The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as challenges and opportunities, next-generation antibody products, Antibody-Drug-Conjugates (ADC), bispecifics, glycosylation, and T-cell engagers are covered. Each topic has been written by leading groups around the world and the book should be of interest to researchers from both academia and industry.Pharmaceutical industryPharmaceutical industry.338.476151Kayser Veysel1367965Datta-Mannan AmitaNjHacINjHaclBOOK9910674373203321Monoclonal Antibody-Directed Therapy3392206UNINA